West Nile Virus

JAMA

Volumn 290, Issue 4, 2003, Pages 524-528

  Petersen, Lyle R ^a   Marfin, Anthony A ^b   Gubler, Duane J ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DIETHYLTOLUAMIDE; IMMUNOGLOBULIN; INSECT REPELLENT; INTERFERON; OSMOTIC AGENT; PERMETHRIN; RIBAVIRIN; STEROID; UNCLASSIFIED DRUG; VIRUS VACCINE; WEST NILE VACCINE;

CLINICAL FEATURE; CULEX; DRUG EFFICACY; ECOLOGY; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HUMAN; MENINGOENCEPHALITIS; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; ANIMAL; BLOOD TRANSFUSION; DISEASE CARRIER; DISEASE TRANSMISSION; EPIDEMIC; MOSQUITO; PATHOGENICITY; PATHOPHYSIOLOGY; UNITED STATES; VIROLOGY; VIRUS INFECTION;

ANIMALS; BLOOD TRANSFUSION; CULICIDAE; DISEASE OUTBREAKS; HUMANS; INSECT VECTORS; UNITED STATES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 0038793357     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.4.524     Document Type: Review

References (41)

1. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-1814.
2. Centers for Disease Control and Prevention. Provisional surveillance summary of the West Nile virus epidemic-United States, January-November 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1129-1133.
3. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis. 2002;2:519-529.
4. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:173-179.
5. Komar N, Langevin S, Hinten S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis. 2003;9:311-322.
6. Southam CM, Moore AE. Induced infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg. 1954;3:19-50.
7. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in south-eastern Romania. Lancet. 1998;352:767-771.
8. Platonov AE, Shipulin GA, Shipulina OY, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis. 2001;7:128-132.
9. Weinburger M, Pitlik SD, Gandacu D, et al. West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis. 2001;7:686-691.
10. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001;7:675-678.
11. Drebot MA, Lindsay R, Barker IK, et al. West Nile virus surveillance and diagnostics: a Canadian perspective. Can J Infect Dis. 2003;14:105-114.
12. Monath TP. Epidemiology. In: Monath TP, ed. St. Louis Encephalitis. Washington, DC: American Public Health Association; 1980:239-312.
13. Centers for Disease Control and Prevention. Intrauterine West Nile virus infection-New York, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1135-1136.
14. Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast feeding-Michigan, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:877-878.
15. Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections-United States, 2002. MMWR Morb Mortal Wkly Rep. 2002; 51:1133-1135.
16. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348:2196-2203.
17. Biggerstaff B, Petersen L. Estimated risk of West Nile virus transmission through blood transfusion in the United States, 2002. Transfusion. (in press).
18. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261-264.
19. Marberg K, Goldblum N, Sterk VV, Jasinska-Klingberg W, Klingberg MA. The natural history of West Nile fever, I: clinical observations during an epidemic in Israel. Am J Hygiene. 1956;64:259-269.
20. Hubálek Z. Comparative symptomatology of West Nile fever. Lancet. 2001;358:254-255.
21. Centers for Disease Control and Prevention. Serosurveys for West Nile virus infection-New York and Connecticut Counties, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:31-39.
22. Hubálek Z, Halouzka J, Juricová Z. West Nile fever in Czechland. Ernerg Infect Dis. 1999;5:594-595.
23. Ceausu E, Erscoiu S, Calistru P, et al. Clinical manifestations in the West Nile virus outbreak. Rom J Virol. 1997;48:3-11.
24. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003;168:1399-1405.
25. Sejvar, JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511-515.
26. Asnis DS, Conetta R, Teixeira AA, Waldman G, Sampson BA. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis. 2000;30:413-418.
27. Ahmed S, Libman R, Wesson K, Ahmed F, Einberg K. Guillain-Barré syndrome: an unusual presentation of West Nile virus infection. Neurology. 2000; 55:144-146.
28. Leis AA, Stokic DS, Polk JL, Dostrow V, Winkelman M. A poliomyelitis-like syndrome associated from West Nile virus infection. N Engl J Med. 2002;347: 1279-1280.
29. Glass JD, Samuels O, Rich MM. Poliomyelitis due to West Nile virus. N Engl J Med. 2002;347:1280-1281.
30. Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis. 2003;9:788-793.
31. Ohry A, Karpin H, Yoeli D, Lazari A, Lerman Y. West Nile virus myelitis. Spinal Cord. 2001;39:662-663.
32. Kelley TW, Prayson RA, Isada CM. Spinal cord disease in West Nile virus infection. N Engl J Med. 2003; 348:564-565.
33. Gilad R, Lampl Y, Sadeh M, Paul M, Dan M. Optic neuritis complicating West Nile virus meningitis in a young adult. Infection. 2003;31:55-56.
34. Vandenbelt S, Shaikh S, Capone A, Williams GA. Multifocal choroiditis associated with West Nile virus encephalitis. Retina. 2003;23:97-99.
35. Bains HS, Jampol LM, Caughron MC, Parnell JR. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol. 2003;121:205-207.
36. New York City Department of Health: West Nile Virus Surveillance and Control: An Update for Healthcare Providers in New York City. New York, NY: City Health Information; 2001.
37. Deubel V, Fiette L, Gounon P, et al. Variations in biological features of West Nile viruses. Ann NY Acad Sci. 2001;951:195-206.
38. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003;77:2578-2586.
39. Beasley DW, Li L, Suderman MT, Barrett AD. West Nile virus strains differ in mouse neurovirulence and binding to mouse or human brain membrane receptor preparations. Virology. 2002;296:17-23.
40. Sampson BA, Armbrustmacher V. West Nile encephalitis: the neuropathology of four fatalities. Ann N Y Acad Sci. 2001;951:172-178.
41. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis. 2003;9:376-379.